Literature DB >> 23755990

Comparison of optimal cytoreduction rates in emergency versus non-emergency admissions for advanced ovarian cancer: a multi-institutional study.

G Mangili1, G Scambia, J Ottolina, F Fanfani, R Viganò, B Costantini, M Candiani, A Fagotti.   

Abstract

AIMS: to investigate whether first referral to the Emergency Department (ED) of a General Hospital is an independent risk-factor for suboptimal debulking compared to a similar population electively admitted to cytoreductive surgery, in a cohort of 307 AOC patients.
METHODS: this is a multicentre case-control study, analyzing a cohort of 307 AOC patients treated at San Raffaele Hospital of Milan (111 Center A) and Gemelli Hospital of Rome (196 Center B) between January 2006/2008 and December 2010. Women are classified as patients admitted to the Hospital from ED (Cases) and out-patients (Controls).
RESULTS: At univariate analysis, Cases significantly differ from Controls in terms of worse ECOG PS, larger ascites, pleuric effusion and peritoneal carcinomatosis. The rate of optimal cytoreduction is statistically lower in the Cases than Controls. At multivariate analysis, significant independent predictors for suboptimal residual disease resulted ED admission, peritoneal carcinosis and mesenteral involvement, supra radical surgery.
CONCLUSIONS: Patients admitted from Emergency Department may have a lower likelihood of optimal cytoreduction, due to their poor clinical characteristics and large diffusion of the disease.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (AOC); (ASA); (ECOG); (ED); (PS); American Society of Anesthesiologists; Cytoreduction; Eastern Cooperative Oncology Group; Emergency admission; Ovarian cancer; Performance status; Residual disease; advanced ovarian cancer; emergency admission; performance status

Mesh:

Year:  2013        PMID: 23755990     DOI: 10.1016/j.ejso.2013.05.011

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  1 in total

1.  Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?

Authors:  Anas Barakat; Aemn Ismail; Quentin Davies; Supratik Chattopadhyay
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.